Cleared Traditional

K943672 - PHACO NEEDLES AND TIPS

K943672 is an FDA 510(k) clearance for PHACO NEEDLES AND TIPS, manufactured by Microsurgical Technology, Inc.. The device is a Class 2 Ophthalmic device with product code HQC cleared through the Traditional 510(k) pathway after a 79-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1994
Decision
79d
Days
Class 2
Risk

K943672 is an FDA 510(k) clearance for the PHACO NEEDLES AND TIPS. Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by Microsurgical Technology, Inc. (Kirkland, US). The FDA issued a Cleared decision on October 13, 1994 after a review of 79 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Microsurgical Technology, Inc. devices

FDA 510(k) Submission Details - K943672

510(k) Number K943672 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 26, 1994
Decision Date October 13, 1994
Days to Decision 79 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
31d faster than avg
Panel avg: 110d · This submission: 79d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQC Device Classification - Class 2, Special Controls

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQC Unit, Phacofragmentation

All 197
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K943672.
STORZ PHACOEMULSIFICATION NEEDLES
K946176 · Storz Instrument Co. · Feb 1995
CASSETTE SYSTEM FOR STORZ
K942945 · Surgin Surgical Instrumentation, Inc. · Dec 1994
STORZ PHACO AND FRAG HANDPIECES
K935926 · Storz Instrument Co. · Nov 1994
PHACO TIPS FOR PHACO FRAGMENTATION MACHINES
K943379 · Oasis Medical, Inc. · Oct 1994
HIGH PERFORMANCE TIPS
K943102 · Surgin Surgical Instrumentation, Inc. · Jul 1994
PHACO KIT
K942515 · Surgin Surgical Instrumentation, Inc. · Jul 1994